How Does Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) Hold Up in Predicting Adverse Outcomes and Prognosis among Patients with Chronic Liver Disease Compared to Other Liver Scoring Systems?

Gosavi Siddharth; Samarth Sangamesh; Amogh Ananda  Rao; Shashank Shastry; Aishwarya  Hulikal; Ayushi  Mendiratta

How Does Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) Hold Up in Predicting Adverse Outcomes and Prognosis among Patients with Chronic Liver Disease Compared to Other Liver Scoring Systems?

Gosavi Siddharth, Samarth Sangamesh, Amogh Ananda Rao, Shashank Shastry, Aishwarya Hulikal, Ayushi Mendiratta

Research output: Contribution to journal › Article › peer-review

Abstract

Chronic liver disease is the progressive destruction of liver for 6 months thereby
impairing clotting factor formation, bile metabolism, and protein synthesis. ChildPugh-Turcotte (CTP) score, model for end-stage liver disease (MELD) and MELD– sodium (Na) are well established calculated parameters to predict prognosis in chronic liver disease (CLD) patients. This study was conducted to determine as to
how aspartate aminotransferase : platelet ratio index (APRI) fares in predicting
adverse outcomes and prognosis among patients with chronic liver disease
compared to other liver scoring.

Original language	English
Pages (from-to)	1053-1057
Number of pages	5
Journal	Journal of evidence based medicine and health care
Volume	8
Issue number	16
Publication status	Published - 19-04-2021

Access to Document

https://www.jebmh.com/articles/how-does-aspartate-aminotransferasetoplatelet-ratio-index-aprihold-up-in-predicting-adverse-outcomes-and-prognosis-among.pdf.pdf

Cite this

Siddharth, G., Sangamesh, S., Rao, A. A., Shastry, S., Hulikal, A., & Mendiratta, A. (2021). How Does Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) Hold Up in Predicting Adverse Outcomes and Prognosis among Patients with Chronic Liver Disease Compared to Other Liver Scoring Systems? Journal of evidence based medicine and health care, 8(16), 1053-1057. https://www.jebmh.com/articles/how-does-aspartate-aminotransferasetoplatelet-ratio-index-aprihold-up-in-predicting-adverse-outcomes-and-prognosis-among.pdf.pdf

@article{c826d10310da4edbbf8aa71eedbcecb1,

title = "How Does Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) Hold Up in Predicting Adverse Outcomes and Prognosis among Patients with Chronic Liver Disease Compared to Other Liver Scoring Systems?",

abstract = "Chronic liver disease is the progressive destruction of liver for 6 months therebyimpairing clotting factor formation, bile metabolism, and protein synthesis. ChildPugh-Turcotte (CTP) score, model for end-stage liver disease (MELD) and MELD– sodium (Na) are well established calculated parameters to predict prognosis in chronic liver disease (CLD) patients. This study was conducted to determine as tohow aspartate aminotransferase : platelet ratio index (APRI) fares in predictingadverse outcomes and prognosis among patients with chronic liver diseasecompared to other liver scoring.",

author = "Gosavi Siddharth and Samarth Sangamesh and Rao, {Amogh Ananda} and Shashank Shastry and Aishwarya Hulikal and Ayushi Mendiratta",

year = "2021",

month = apr,

day = "19",

language = "English",

volume = "8",

pages = "1053--1057",

journal = "Journal of evidence based medicine and health care",

issn = "2349-2562",

number = "16",

}

Siddharth, G, Sangamesh, S, Rao, AA, Shastry, S, Hulikal, A & Mendiratta, A 2021, 'How Does Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) Hold Up in Predicting Adverse Outcomes and Prognosis among Patients with Chronic Liver Disease Compared to Other Liver Scoring Systems?', Journal of evidence based medicine and health care, vol. 8, no. 16, pp. 1053-1057. <https://www.jebmh.com/articles/how-does-aspartate-aminotransferasetoplatelet-ratio-index-aprihold-up-in-predicting-adverse-outcomes-and-prognosis-among.pdf.pdf>

How Does Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) Hold Up in Predicting Adverse Outcomes and Prognosis among Patients with Chronic Liver Disease Compared to Other Liver Scoring Systems? / Siddharth, Gosavi; Sangamesh, Samarth; Rao, Amogh Ananda et al.
In: Journal of evidence based medicine and health care, Vol. 8, No. 16, 19.04.2021, p. 1053-1057.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - How Does Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) Hold Up in Predicting Adverse Outcomes and Prognosis among Patients with Chronic Liver Disease Compared to Other Liver Scoring Systems?

AU - Siddharth, Gosavi

AU - Sangamesh, Samarth

AU - Rao, Amogh Ananda

AU - Shastry, Shashank

AU - Hulikal, Aishwarya

AU - Mendiratta, Ayushi

PY - 2021/4/19

Y1 - 2021/4/19

N2 - Chronic liver disease is the progressive destruction of liver for 6 months therebyimpairing clotting factor formation, bile metabolism, and protein synthesis. ChildPugh-Turcotte (CTP) score, model for end-stage liver disease (MELD) and MELD– sodium (Na) are well established calculated parameters to predict prognosis in chronic liver disease (CLD) patients. This study was conducted to determine as tohow aspartate aminotransferase : platelet ratio index (APRI) fares in predictingadverse outcomes and prognosis among patients with chronic liver diseasecompared to other liver scoring.

AB - Chronic liver disease is the progressive destruction of liver for 6 months therebyimpairing clotting factor formation, bile metabolism, and protein synthesis. ChildPugh-Turcotte (CTP) score, model for end-stage liver disease (MELD) and MELD– sodium (Na) are well established calculated parameters to predict prognosis in chronic liver disease (CLD) patients. This study was conducted to determine as tohow aspartate aminotransferase : platelet ratio index (APRI) fares in predictingadverse outcomes and prognosis among patients with chronic liver diseasecompared to other liver scoring.

M3 - Article

SN - 2349-2562

VL - 8

SP - 1053

EP - 1057

JO - Journal of evidence based medicine and health care

JF - Journal of evidence based medicine and health care

IS - 16

ER -

How Does Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) Hold Up in Predicting Adverse Outcomes and Prognosis among Patients with Chronic Liver Disease Compared to Other Liver Scoring Systems?

Abstract

Access to Document

Fingerprint

Cite this